Jun 04,2020

Nanox, maker of a low-cost scanning service to replace X-rays, expands Series B to $51M

Nanox, a startup out of Israel that has developed a small, low-cost scanning system and “medical screening as a service” to replace the costly and large machines and corresponding software typically used for X-rays, CAT scans, PET scans and other body imaging services, is today announcing that it has raised $20 million from a strategic investor, South Korean carrier SK Telecom. The funding is technically an extension of Nanox’s previous round, which was announced earlier this year at $26 million with backing from Foxconn, FujiFilm and more. Nanox says that the full round is now closed off at $51 million, with the company having raised $80 million since launching almost a decade ago, in 2011.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jul 13,2020

Paige Secures Additional $15M from Goldman Sachs, for a Total Series B Funding Round of $70M

Paige, a global leader in computational pathology, today announced it received an additional $15M from Goldman Sachs Merchant Banking Division, totaling $20M from the firm. The funding will be added to previously announced Series B financing, bringing the total round to $70M, including an additional investment from Healthcare Venture Partners of $5M on top of their previous $10M investment. The funding brings the Company’s total capital raised to over $95M.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jul 28,2020

Nanox raises $59M for low-cost, downsized scanning tech to replace X-rays

Nanox is announcing another big step ahead in that plan: it has raised another $59 million in funding, closing out its Series B at $110 million, to continue building its full-body scanning hardware and securing more customers after already securing deals in 13 countries. The money is coming from a range of strategic investors that include SK Telecom, Industrial Alliance (the Canadian insurance group), Foxconn and Yozma Korea, and it has arrived swiftly on the heels of $51 million delivered in two tranches, the most recent being $20 million in June from strategic investor SK Telecom, which is building a factory to manufacture Nanox hardware in South Korea (there is another factory in Japan).

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Sep 02,2020

SoftBank Vision Fund 2 leads $100 million Series C in digital therapeutics company Biofourmis

Biofourmis, which combines AI-based data analytics and biosensors to monitor the progress of medical treatments, has raised funding from one of the world’s most high-profile investors. The digital therapeutics company, which launched in Singapore and is now headquartered in Boston, announced today it closed a $100 million Series C led by SoftBank Vision Fund 2, with participation from returning investors Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Sep 14,2020

Voluntis obtains €2 million in non-dilutive financing

Voluntis, a leader in digital therapeutics, announces today that it has obtained a state-guaranteed loan (Prêt Garanti par l’Etat, or PGE in France) from BNP Paribas. This €2 million loan with an initial term of one year and is fully repayable on maturity[1]. Repayment of the amounts due may be deferred again, at the company’s option, until September 2026. The French State guarantees 90% of the amounts due.

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
Oct 28,2020

Sidekick Health scores $20M for its gamified digital care platform

Nordic digital therapeutics company, Sidekick Health, has closed a $20 million Series A led by pan-European VC Wellington Partners and healthcare focused VC Asabys Partners. Existing investors, Novator and Frumtak Ventures, also participated in the oversubscribed round.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Nov 23,2020

Voluntis successfully completes a capital increase of €5.9 million and finalizes the financing of its strategic roadmap

Voluntis, a leader in the field of digital therapeutics, announces today the completion of a capital increase without preferential subscription rights exclusively reserved to the category of investors defined below for a total amount of €5.9 million. The securities were subscribed by quality European investors, most of them specialized in the healthcare sector, including Debiopharm Innovation Fund, Corporate fund of Swiss company Debiopharm, and Indigo, the holding company of M. Eric Carreel, Chairman & co-founder of Withings, which strengthened its position.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Dec 18,2020

Voluntis obtains €3 million of additional non-dilutive loans and optimizes its existing financing

Voluntis, a leader in the field of digital therapeutics, announces that it has been granted new state-guaranteed loans (Prêt Garanti par l’Etat, or PGE in France) for a total amount of €3 million from BNP Paribas and Crédit du Nord and the optimization of the Company’s financial structure.

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
Jul 01,2019

Belong.Life raises $14 million to expand its digital cancer support network

Tel Aviv- and New York-based Belong.Life, a startup developing a digital support network for cancer patients that uses AI to create personalized experiences, today announced that it’s raised $14 million in series B funding led by Iqvia, with participation from The Group Ventures and other existing investors. The fresh funds bring the startup’s total raised to nearly $30 million following a $5 million series A in June 2015, and cofounder and CEO Eliran Malki says they’ll be used to expand Belong’s reach into new markets and diseases.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Sep 27,2019

Healthtech Startup Onco.com Secured $7 million In Series A Funding Round

Healthtech startup Onco.com has raised $7 million in its Series A funding round, which saw participation from Accel Partners, Chiratae Venture (earlier known as IDG Ventures) and Dream Incubator. The Bengaluru-headquartered startup is an online healthcare aggregator with focus on cancer care.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING